TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million
TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million
Read moreWed, 12th Mar 2014 07:07
TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million
Read moreTOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million
Read moreLONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health
Read more(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.
Read moreLONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback
Read more(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.
Read more(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.
Read moreHikma adds two biosimilars to portfolio with Gedeon Richter agreement
Read more(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.
Read moreTOP NEWS: Hikma confirms 2021 guidance amid strong performance
Read more(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.
Read more(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreLONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco
Read moreLONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills
Read more